Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America
Clinical trial NCT01518244 · COMPLETED
Trial details
- NCT number
- NCT01518244
- Sponsor
- Alcon Research
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2013-02-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.